MD News and Press, Mednax Inc. From 06/21/22

Mednax (NYSE:MD) said it will change its corporate name to Pediatrix Medical Group Inc., effective after the close of the market on July 1. The company added that its common stock will continue to trade on the NYSE under the current ticker, MD. "This underscores our position as a leading...

Mednax, Inc. (NYSE: MD) today announced that it will change its corporate name to Pediatrix Medical Group, Inc., effective after the close of the market on July 1, 2022. The Company’s common stock will continue to trade on the New York Stock Exchange under the current ticker symb...

The white-hot housing market that only intensified during the pandemic is starting to ease as higher mortgage rates and still rising home prices push some prospective homebuyers to the sidelines.   In the past week: May housing starts and building permits both fell more than expected ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good things sometimes come in small packages. These seven cheap stocks under $20 all have the potential to double soon. However, for that to happen, the economy has to cooperate. So, inflation must go, or at the very least...

Mednax (NYSE:MD) announced two appointments to strengthen its operating and clinical leadership. James D. Swift, M.D. is appointed as COO and Curtis B. Pickert, M.D. as Chief Physician Executive. Both have been with the company for over a decade and have held expanding leadersh...

James D. Swift, M.D. Appointed Chief Operating Officer; Curtis B. Pickert, M.D. Appointed Chief Physician Executive Mednax, Inc. (NYSE: MD) today announced two appointments to further strengthen its operating and clinical leadership. The Company named James D. Swift, M.D. as...

Silver Ring Value Partners provides investment advisory services. The Company offers portfolio management, financial planning, and trading services. Silver Ring Value Partners serves investors in the State of Massachusetts. The portfolio’s market value is roughly unchanged thus...

MEDNAX, Inc. (MD) Q1 2022 Earnings Conference Call April 28, 2022, 09:00 ET Company Participants Charles Lynch - SVP, Finance, Strategy & IR Mark Ordan - CEO & Director Marc Richards - EVP & CFO James Swift - Chief Development Officer Conference Call Participants Tao Qiu - Stifel,...

Mednax (NYSE:MD) stock declined April 28 following the company's Q1 results. The Sunrise, Fla.-based company, which provides neonatal care services, saw non-GAAP EPS rise by +37.5% Y/Y to $0.33, which beat analysts' estimates. Q1 revenue rose +7.94% Y/Y to $482.23M. The company said the growt...

Mednax press release (NYSE:MD): Q1 Non-GAAP EPS of $0.33 beats by $0.06. Revenue of $482.23M (+7.9% Y/Y) beats by $10.94M. “Our bottom line results were in line with our expectations and reflect continued patient volume growth,” said Mark S. Ordan, Chief Executive Officer o...